Skip to main content
Erschienen in: Endocrine 1/2019

03.06.2019 | Original Article

Development of a metabolic syndrome severity score and its association with incident diabetes in an Asian population—results from a longitudinal cohort in Singapore

verfasst von: Serena Low, Kay Chin Jonathon Khoo, Jiexun Wang, Bastari Irwan, Chee Fang Sum, Tavintharan Subramaniam, Su Chi Lim, Tack Keong Michael Wong

Erschienen in: Endocrine | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Metabolic syndrome (MetS) is a constellation of clinical factors that indicates elevated risk of diabetes. It is diagnosed based on three or more abnormalities in its components. This does not take into account that MetS can likely present as a continuum of risk. We aim to develop a MetS severity score and assess its association with incident diabetes.

Methods

In total, 4149 subjects without baseline diabetes participated in a community screening programme in 2013–2017. MetS was defined according to International Diabetes Federation criteria. A MetS severity z-score was derived from standardised loading coefficients of a confirmatory factor analysis for waist circumference, triglycerides, HDL-cholesterol, blood pressure and fasting plasma glucose (FPG). Multivariable cox proportional hazards regression model was used to assess the risk of diabetes by the score with adjustment for demographics and MetS components.

Results

Diabetes occurred in 130 subjects. Quintile 5 of the baseline MetS severity z-score was significantly associated with development of diabetes even in fully adjusted model with HR 2.63 (95% CI: 1.04–6.64; p = 0.040). The relationship between MetS and incident diabetes became attenuated and non-significant in fully adjusted model with HR 0.67 (95% CI: 0.34–1.29; p = 0.228). Mediation analysis showed that MetS severity z-score accounted 61.0% of the association between increasing body mass index and development of diabetes (p < 0.001).

Conclusions

The MetS severity z-score is an inexpensive and clinically-available continuous measure of MetS to identify individuals at high risk of diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat M.J. Gurka, C.L. Ice, S.S. Sun, M.D. Deboer, A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences. Cardiovasc. Diabetol. 11, 128 (2012)CrossRefPubMedPubMedCentral M.J. Gurka, C.L. Ice, S.S. Sun, M.D. Deboer, A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences. Cardiovasc. Diabetol. 11, 128 (2012)CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat S. de Ferranti, D. Mozaffarian, The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin. Chem. 54, 945–955 (2008)CrossRefPubMed S. de Ferranti, D. Mozaffarian, The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin. Chem. 54, 945–955 (2008)CrossRefPubMed
6.
Zurück zum Zitat M.D. DeBoer, Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions. Nutrition 29, 379–386 (2013)CrossRefPubMed M.D. DeBoer, Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions. Nutrition 29, 379–386 (2013)CrossRefPubMed
7.
Zurück zum Zitat M.J. Gurka, S.H. Golden, S.K. Musani et al. Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study. Diabetologia 60, 1261–1270 (2017)CrossRefPubMedPubMedCentral M.J. Gurka, S.H. Golden, S.K. Musani et al. Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study. Diabetologia 60, 1261–1270 (2017)CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat G.I. Shulman, Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N. Engl. J. Med. 371, 1131–1141 (2014)CrossRefPubMed G.I. Shulman, Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N. Engl. J. Med. 371, 1131–1141 (2014)CrossRefPubMed
9.
Zurück zum Zitat C. Lorenzo, M. Okoloise, K. Williams, M.P. Stern, S.M. Haffner, The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26, 3153–3159 (2003)CrossRefPubMed C. Lorenzo, M. Okoloise, K. Williams, M.P. Stern, S.M. Haffner, The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26, 3153–3159 (2003)CrossRefPubMed
10.
Zurück zum Zitat M.D. DeBoer, M.J. Gurka, Clinical utility of metabolic syndrome severity scores: considerations for practitioners. Diabetes Metab. Syndr. Obes. 10, 65–72 (2017)CrossRefPubMedPubMedCentral M.D. DeBoer, M.J. Gurka, Clinical utility of metabolic syndrome severity scores: considerations for practitioners. Diabetes Metab. Syndr. Obes. 10, 65–72 (2017)CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat B.D. Dimitrov, K.M. Bahchevanov, P.A. Atanassova et al. Metabolic syndrome severity score: range and associations with cardiovascular risk factors. Arch. Med. Sci. Atheroscler. Dis. 1, e90–e97 (2016)CrossRefPubMedPubMedCentral B.D. Dimitrov, K.M. Bahchevanov, P.A. Atanassova et al. Metabolic syndrome severity score: range and associations with cardiovascular risk factors. Arch. Med. Sci. Atheroscler. Dis. 1, e90–e97 (2016)CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat J.K. Gustafson, L.B. Yanoff, B.D. Easter et al.The stability of metabolic syndrome in children and adolescents. J. Clin. Endocrinol. Metab. 94, 4828–4834 (2009)CrossRefPubMedPubMedCentral J.K. Gustafson, L.B. Yanoff, B.D. Easter et al.The stability of metabolic syndrome in children and adolescents. J. Clin. Endocrinol. Metab. 94, 4828–4834 (2009)CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat C. Li, E.S. Ford, T.T. Huang, S.S. Sun, E. Goodman, Patterns of change in cardiometabolic risk factors associated with the metabolic syndrome among children and adolescents: the Fels Longitudinal Study. J. Pediatr. 155, S5.e9–e16 (2009)CrossRef C. Li, E.S. Ford, T.T. Huang, S.S. Sun, E. Goodman, Patterns of change in cardiometabolic risk factors associated with the metabolic syndrome among children and adolescents: the Fels Longitudinal Study. J. Pediatr. 155, S5.e9–e16 (2009)CrossRef
14.
Zurück zum Zitat M.D. DeBoer, M.J. Gurka, J.G. Woo, J.A. Morrison, Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study. Diabetologia 58, 2745–2752 (2015)CrossRefPubMedPubMedCentral M.D. DeBoer, M.J. Gurka, J.G. Woo, J.A. Morrison, Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study. Diabetologia 58, 2745–2752 (2015)CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat M.J. Gurka, S.L. Filipp, T.A. Pearson, M.D. DeBoer, Assessing baseline and temporal changes in cardiometabolic risk using metabolic syndrome severity and common risk scores. J. Am. Heart Assoc. 7, e009754 (2018)CrossRefPubMedPubMedCentral M.J. Gurka, S.L. Filipp, T.A. Pearson, M.D. DeBoer, Assessing baseline and temporal changes in cardiometabolic risk using metabolic syndrome severity and common risk scores. J. Am. Heart Assoc. 7, e009754 (2018)CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat C.G. Magnussen, S. Cheriyan, M.A. Sabin et al. Continuous and dichotomous metabolic syndrome definitions in youth predict adult type 2 diabetes and carotid artery intima media thickness: The cardiovascular risk in young finns study. J. Pediatr. 171, 97–103.e1-e3 (2016)CrossRefPubMed C.G. Magnussen, S. Cheriyan, M.A. Sabin et al. Continuous and dichotomous metabolic syndrome definitions in youth predict adult type 2 diabetes and carotid artery intima media thickness: The cardiovascular risk in young finns study. J. Pediatr. 171, 97–103.e1-e3 (2016)CrossRefPubMed
17.
Zurück zum Zitat S. Low, K.C.J. Khoo, B. Irwan et al. The role of triglyceride glucose index in development of type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 143, 43–49 (2018)CrossRefPubMed S. Low, K.C.J. Khoo, B. Irwan et al. The role of triglyceride glucose index in development of type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 143, 43–49 (2018)CrossRefPubMed
18.
Zurück zum Zitat Roche. Glucose H. K. Gen.3: Cobas. (Roche Diagnostics GmBH, Mannheim, Germany, 2016) Roche. Glucose H. K. Gen.3: Cobas. (Roche Diagnostics GmBH, Mannheim, Germany, 2016)
19.
Zurück zum Zitat Roche. Triglycerides: Cobas. (Roche Diagnostics GmbH, Mannheim, Germany, 2016) Roche. Triglycerides: Cobas. (Roche Diagnostics GmbH, Mannheim, Germany, 2016)
20.
Zurück zum Zitat Roche. HDL-Cholesterol Plus Generation: Cobas. (Roche Diagnostics GmBH, Mannheim, Germany, 2016) Roche. HDL-Cholesterol Plus Generation: Cobas. (Roche Diagnostics GmBH, Mannheim, Germany, 2016)
21.
Zurück zum Zitat American Diabetes Association, Standards of medical care in diabetes—2017. Diabetes Care 40, S1–S135 (2017)CrossRef American Diabetes Association, Standards of medical care in diabetes—2017. Diabetes Care 40, S1–S135 (2017)CrossRef
22.
Zurück zum Zitat V.S. Effoe, A. Correa, H. Chen, M.E. Lacy, A.G. Bertoni, High-sensitivity C-reactive protein is associated with incident type 2 diabetes among African Americans: The Jackson heart study. Diabetes Care 38, 1694–1700 (2015)CrossRefPubMedPubMedCentral V.S. Effoe, A. Correa, H. Chen, M.E. Lacy, A.G. Bertoni, High-sensitivity C-reactive protein is associated with incident type 2 diabetes among African Americans: The Jackson heart study. Diabetes Care 38, 1694–1700 (2015)CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat M.I. Schmidt, B.B. Duncan, H. Bang et al. Identifying individuals at high risk for diabetes: The atherosclerosis risk in communities study. Diabetes Care 28, 2013–2018 (2005)CrossRefPubMed M.I. Schmidt, B.B. Duncan, H. Bang et al. Identifying individuals at high risk for diabetes: The atherosclerosis risk in communities study. Diabetes Care 28, 2013–2018 (2005)CrossRefPubMed
24.
Zurück zum Zitat T.A. Brown. Confirmatory Factor Analysis for Applied Research. (The Guildford Press, New York, 2006) T.A. Brown. Confirmatory Factor Analysis for Applied Research. (The Guildford Press, New York, 2006)
25.
Zurück zum Zitat R.D. De Veaux, P.F. Velleman, D.E. Bock. Stats: Data and Models. (Pearson, Boston, 2016) R.D. De Veaux, P.F. Velleman, D.E. Bock. Stats: Data and Models. (Pearson, Boston, 2016)
26.
Zurück zum Zitat StataCorp. Structural Equation Modeling Reference Manual: Release 13. (Stata Press, Texas, 2013) StataCorp. Structural Equation Modeling Reference Manual: Release 13. (Stata Press, Texas, 2013)
27.
Zurück zum Zitat S.M. Grundy, J.I. Cleeman, S.R. Daniels et al.Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735–2752 (2005)CrossRef S.M. Grundy, J.I. Cleeman, S.R. Daniels et al.Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735–2752 (2005)CrossRef
28.
Zurück zum Zitat R.M. Baron, D.A. Kenny, The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 51, 1173–1182 (1986)CrossRefPubMed R.M. Baron, D.A. Kenny, The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 51, 1173–1182 (1986)CrossRefPubMed
Metadaten
Titel
Development of a metabolic syndrome severity score and its association with incident diabetes in an Asian population—results from a longitudinal cohort in Singapore
verfasst von
Serena Low
Kay Chin Jonathon Khoo
Jiexun Wang
Bastari Irwan
Chee Fang Sum
Tavintharan Subramaniam
Su Chi Lim
Tack Keong Michael Wong
Publikationsdatum
03.06.2019
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01970-5

Weitere Artikel der Ausgabe 1/2019

Endocrine 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.